What a treatment is, who regulates it, and what to ask. 186 articles, newest first.
CO2 and erbium:YAG are ablative laser families, not complete treatment plans. Compare the exact device and clearance, fractional or full-field delivery, settings, passes, endpoint, skin characteristics, anesthesia, aftercare, and operator experience—not generic promises that one wavelength is deeper or gentler.
A standard tummy tuck uses a horizontal lower-abdominal pattern and advances tissue vertically; a fleur-de-lis design adds a vertical midline excision for substantial side-to-side and upper-central excess. The added vector can improve contour but creates a permanent vertical scar and T-junction.
“Microdosing” is not a standardized FDA label term, pen clicks are not a universal dose unit, and syringe units measure volume rather than drug mass. Verify the product, concentration, prescribed milligrams, corresponding volume, device, and written directions without reverse-engineering conversions.
Conventional liposuction reduces selected subcutaneous fat; high-definition liposuction adds deliberate superficial and deep contouring around underlying anatomy, sometimes with fat addition or energy-assisted steps. “HD” is not an FDA device class or proof of etched muscle, skin tightening, or superior safety.
A mini tummy tuck generally addresses a limited lower-abdominal zone; a full abdominoplasty reaches more broadly and commonly includes navel work and a wider wall-repair decision. Neither label is standardized enough to book from alone. Compare skin, fascia, fat, navel, scar, anesthesia, and recovery.
Paradoxical adipose hyperplasia is a recognized delayed cryolipolysis complication in which treated fat enlarges instead of shrinking, often forming a firm contour months later that does not resolve on its own. It differs from early swelling, incomplete reduction, weight change, or another mass.
Preservation rhinoplasty generally keeps more native dorsal structure while changing height; structural rhinoplasty more often reduces and reconstructs components with sutures or grafts. Neither name defines the incision, tip, airway work, candidacy, or result, and many operations combine both.
SARMs marketed for muscle or performance are not FDA-approved drugs and cannot lawfully be sold as dietary supplements. Prescription testosterone products have specific approved indications. A bodybuilding supplement may contain supplement ingredients, an undeclared drug, or a mislabeled SARM.
Sliding genioplasty cuts and repositions a person's chin bone with fixation; a chin implant adds a shaped permanent device over the skeleton. Compare skeletal geometry, movement needed, bite and airway context, soft tissue, device tolerance, scars, recovery, and revision options.
No testosterone product is FDA approved specifically to treat female sexual dysfunction in the United States. Off-label prescribing and patient-specific compounding are separate pathways with different evidence, labeling, quality, dosing, and monitoring records.
Injecting botulinum toxin into the trapezius for cosmetic shoulder or neck contour—often called “TrapTox”—is not an FDA-approved BOTOX Cosmetic indication. Evidence is early and protocols vary. Verify the exact product, off-label purpose, dose map, functional baseline, tradeoffs, and follow-up.
Several hyaluronic-acid fillers have product-specific FDA approvals for defined infraorbital volume deficits in adults. Approval applies to the named formulation, age, anatomy, plane, labeling, and technique—not every filler, tear trough, eyelid, orbital area, injection plane, or patient.
An upper lip lift shortens the skin distance between nose and lip, changing vermilion and tooth show through tissue excision and a permanent scar. Filler adds temporary volume and shape; it cannot remove philtral skin. The comparison begins with the anatomical job, not desired “fullness.”
A 1726-nm acne-laser clearance belongs to the named prescription device and stated inflammatory-acne indication. It does not authorize every platform, promise permanent clearing, treat acne scars, or prove superiority to medicine. Verify the model, 510(k), protocol, endpoint, evidence window, operator, and follow-up.
Alexandrite, diode, and long-pulsed Nd:YAG are laser families, not fixed rankings. Wavelength affects melanin absorption and penetration, while treatment also depends on platform, pulse, fluence, spot, cooling, skin response, hair target, area, operator, and schedule. Compare the complete settings strategy.
Two bounded 2026 filler approvals now exist: SKINVIVE by JUVÉDERM for specified injection to reduce neck lines in adults over 21, and RADIESSE diluted 1:2 with sterile saline for subdermal correction of décolleté wrinkles in patients 22 and older. They do not cover every filler, dilution, area, technique, or provider.
A BBL uses harvested fat through liposuction and subcutaneous grafting; buttock implant surgery places a manufactured device in a planned pocket. Compare donor-fat needs, incisions, device records, Florida rules, surveillance, complications, revision options, and the full safety system—not projection alone.
An authorized noninvasive body-contouring device may target local circumference, a fat bulge, muscle tone, or cellulite appearance; FDA says contouring does not treat obesity or cause weight loss. A weight-loss or weight-management device has its own indication, population, mechanism, evidence, and follow-up.
Botulinum toxin and dermal filler solve different appearance problems. A useful consultation starts by watching what changes at rest and in motion, naming whether the goal is less muscle pull or more contour, and checking the exact product, site, label, risks, and follow-up plan.
Recovery boots, condition-specific medical pumps, and perioperative compression systems may all inflate around a limb, but they are not interchangeable. Compare the exact device, FDA record, intended use, sleeve, pressure sequence, screening, protocol, monitoring, outcome, and responsible clinician.
A blunt cannula can change entry points, tissue passage, bruising, and some observed vascular-risk estimates, but it cannot eliminate intravascular injection. A needle can offer direct placement in selected planes. Compare anatomy, product, depth, technique, volume, visualization, injector, and emergency plan.
Weight loss during GLP-1 treatment can include measured lean-mass loss, but DXA lean mass is not identical to skeletal muscle, strength, or function. A useful program names the product, time point, measurement method, compartments, functional measures, trend, and interpreting clinician.
Finasteride 1 mg has a U.S. FDA-approved male-pattern-hair-loss indication; dutasteride products are approved for benign prostatic hyperplasia, so hair-loss use is off label. Oral, compounded topical, and combination offers need separate product, evidence, exposure, and safety records.
Enclomiphene, clomiphene, and testosterone are different product paths. The U.S. has no FDA-approved finished enclomiphene drug; clomiphene's approval is for a female ovulatory indication and male use is off label; testosterone products have product-specific approvals and labels.
An eyebrow transplant relocates living follicles that keep growing hair; microblading deposits pigment into skin to create hair-like marks. Compare the desired endpoint, donor hair and grooming, pigment and fading, scars, Florida artist or clinical records, maintenance, reversibility limits, and correction plan.
An FDA-approved intravenous ascorbic-acid product has a narrow labeled use for short-term treatment of scurvy when oral administration is not possible, insufficient, or contraindicated. That approval does not establish IV vitamin C as an FDA-approved wellness, immunity, anti-aging, fatigue, or cancer treatment.
A tummy tuck primarily reshapes the front of the abdomen; a lower body or belt lift extends skin excision around the trunk and may affect the waist, buttocks, and outer thighs. Compare the exact incision and region map, wall work, staging, risk, recovery support, and quote—not the package name.
Metformin is FDA approved for product-specific diabetes uses, not as an anti-aging or longevity drug. Animal experiments, mechanisms, biomarkers, and observational associations can motivate trials, but none alone proves that metformin extends healthy human lifespan outside an established clinical indication.
Mini and full facelift are not standardized procedure grades. Compare two plans by the exact face and neck regions treated, incision and dissection map, tissue layers moved, adjuncts, anesthesia, facility, scar and recovery plan, and what each operation intentionally leaves unchanged.
Foundayo (orforglipron) and Wegovy tablets (semaglutide) are FDA-approved oral weight-management drugs, but they are different molecules with different labels, administration instructions, dose systems, evidence, contraindications, and continuity plans. Compare the exact finished products, not the phrase “GLP-1 pill.”
Piezoelectric rhinoplasty uses an ultrasonic tool for bone work; conventional techniques use osteotomes and rasps. The tool may affect precision and early recovery measures, but it does not define the operation or guarantee long-term shape or airway. Compare the bone plan, access, evidence, surgeon, and endpoints.
“P-shot” is a marketing label, not one standardized, FDA-approved erectile-dysfunction treatment. Verify the diagnosis and responsible urology care, blood collection and PRP preparation, injection protocol, comparator, endpoints, evidence limits, adverse-event plan, and every device or approval claim.
Primary rhinoplasty operates on a nose without prior rhinoplasty; revision rhinoplasty must account for altered cartilage, bone, skin-soft-tissue envelope, scar, blood supply, airway, grafts, implants, and expectations from one or more earlier operations. The word “revision” does not identify the actual reconstruction.
Smooth and textured describe an implant's shell surface, not fill, shape, size, profile, or pocket. FDA says BIA-ALCL risk is higher with textured implants than smooth implants. Verify the exact model, current availability, labeling, device history, placement, surveillance, and revision plan.
Thigh liposuction removes selected fat but does not excise redundant skin. A thigh lift removes and repositions skin, may include fat treatment, and creates a longer scar. Compare skin quality, fat, inner versus outer thigh, scar tolerance, stability, and recovery support.
A transconjunctival lower blepharoplasty reaches the fat compartments from inside the eyelid; a transcutaneous approach uses an external incision near the lash line and can directly address skin and muscle. Neither label defines the fat plan, lid support, skin treatment, scar, adjuncts, or risk by itself.
Upper-arm liposuction reduces selected subcutaneous fat; an arm lift removes loose skin and may include fat removal. The meaningful tradeoff is residual laxity versus a longer permanent scar, with weight stability, tissue quality, movement, and recovery in the same record.
Fat transfer moves harvested fat into the breast; implants add a manufactured device with defined dimensions. The meaningful comparison is not natural versus artificial—it is desired volume, donor tissue, graft retention, imaging changes, implant surveillance, scars, and the likelihood of staged or future surgery.
Inframammary, periareolar, and transaxillary incisions reach the implant pocket from different directions. Scar location is only one tradeoff: exposure, tissue crossed, sensation, lactation evidence, device constraints, pocket control, and future re-entry also belong in the plan.
Implant volume in cubic centimeters does not determine base width, projection, height, or the final breast shape by itself. Profile is a product-line label, cup size is not a standardized surgical unit, and the choice has to fit measured breast and chest dimensions.
Over-muscle, under-muscle, subfascial, and dual-plane placements change tissue coverage, animation, dissection, and revision options. No pocket is universally best; the choice must fit implant dimensions, breast tissue, activity, skin, chest anatomy, and the exact operation.
A breast reduction removes meaningful breast volume and weight; a breast lift reshapes and repositions the existing breast envelope with little size reduction as its primary job. A reduction usually includes lifting steps, but a lift is not automatically a reduction.
Capsular contracture is tightening of scar tissue around a breast implant that may cause firmness, pain, displacement, or visible distortion. Baker grades are a shorthand, not a complete diagnosis; evaluation should document symptoms, implant condition, anatomy, and other causes before a revision is chosen.
Deep-plane and SMAS facelift labels describe different ways of releasing, repositioning, and securing facial tissues, but neither name is a standardized outcome grade. Current reviews do not justify a universal claim that one is safer, more natural, or longer-lasting for every face.
Breast implants are not lifetime devices, but ten years is not an automatic replacement deadline. Reoperation should follow the exact implant, symptoms, imaging when indicated, examination findings, preferences, and current labeling—not a calendar alone.
A drainless tummy tuck usually substitutes progressive-tension or quilting sutures for routine external drains; it is not simply the same operation with the tubes omitted. Both approaches can be reasonable, and neither guarantees freedom from seroma, aspiration, infection, or an unplanned drain.
A medication program and a metabolic or bariatric operation are not interchangeable doses of the same intervention. They use different eligibility frameworks, treatment exposures, endpoints, monitoring plans, risk windows, and long-term follow-up systems.
Liposuction removes accessible fat; excision directly removes firm gland or other tissue and can address skin or the nipple-areola complex. Many operations combine them. Before technique, confirm what tissue is present and whether a medical cause or suspicious finding needs its own evaluation.
